Company Announcements

Noteholders’ Consent Solicitation Launch

Source: RNS
RNS Number : 9058D
PAO Novatek
24 October 2022


Adobe Systems




Noteholders' Consent Solicitation Launch

Moscow, 24 October 2022. PAO NOVATEK ("NOVATEK") announced the launch of consent solicitation process ("Consent Solicitation") in relation to the outstanding USD 1.0 billion notes (ISIN XS0864383723 - Reg S, ISIN US66989PAC41 - Rule 144A) due December 2022 with annual coupon rate 4.422% ("Notes") issued by Novatek Finance DAC ("Issuer").

Rationale for the Consent Solicitation

NOVATEK adheres to meeting its obligations to all Noteholders and protecting their interests. Due to current disruptions in the international payment infrastructure, as well as recent regulatory changes in the Russian Federation regarding the servicing of bonds issued by foreign organizations, there is a material risk a payment under the Notes could not be performed to the Noteholders on the due and equal basis unless certain appointments and amendments to the Notes documentation are approved by the Noteholders.

In order to secure proper and timely payments to the Noteholders, NOVATEK is seeking the consent of the Noteholders to approve appointment of the new Trustee, new Share Trustee, as well as a number of amendments to the transaction documents under the Notes, including the Trust Deed, the Paying Agency Agreement and the Loan Agreement.

General Conditions to the Consent Solicitation

Capitalized terms used in this announcement but not defined herein have the meanings given to them in the Consent Solicitation Memorandum as of 24 October 2022.

·    The full terms and conditions are set forth in the Memorandum as of 24 October 2022.

·            Launch Notice is available at .

·    Copies of the Consent Solicitation Memorandum can be obtained by registering on the Consent Solicitation Website at

·    To participate in the Consent Solicitation, a Noteholder should deliver a valid Consent Instruction to the Information and Tabulation Agent by no later than the Consent Deadline by uploading the completed Consent Instruction on the Consent Solicitation Website.

·    Only Noteholders who hold the Notes as of the Record Date may submit Consent Instructions.


Indicative Timetable

·    Commencement of the Consent Solicitation - 24 October 2022.

·    Record Date - 9 November 2022.

·    Consent Deadline (the final deadline for the submission of Consent Instructions) - not later than 11 November 2022 (5:00 p.m. London time).

·    Meeting - 15 November 2022 (5:00 p.m. London time).

·    Results Announcement - as soon as reasonably practicable after the Meeting.

Questions and requests for assistance in connection with the delivery of Consent Instruction may be directed to the Information and Tabulation Agent.

Information and Tabulation Agent:

i2 Capital Markets Ltd

128 City Road

London, EC1V 2NX

United Kingdom


Phone: +44 203 633 1212

Consent Solicitation Website:





For further information, please visit or contact:

Press Service
+7 (495) 721 2207

Investor Relations
+7 (495) 730 6013


PAO NOVATEK is the largest independent natural gas producer in Russia, and in 2017, entered the global LNG market by successfully launching the Yamal LNG project. Founded in 1994, the Company is engaged in the exploration, production, processing and marketing of natural gas and liquid hydrocarbons. Upstream activities of the Company's subsidiaries and joint ventures are concentrated mainly in the prolific Yamal-Nenets Autonomous Region, which is the world's largest natural gas producing area and accounts for approximately 80% of Russia's natural gas production and approximately 15% of the world's gas production. NOVATEK is a public joint stock company established under the laws of the Russian Federation.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.